Cortexyme
Latest round
- Series B
Last raised
- May 2018
Total raised
- $93M
Investors
- 11
About Cortexyme
Founded in 2012 and based in California, US, Cortexyme, Inc. is a biopharmaceutical company that researches and develops treatments for Alzheimer's disease. They develop treatments for altering the course of Alzheimer's and other neurological diseases by targeting a specific pathogen tied to neurodegeneration.
Who invested in Cortexyme
11 investors across 3 rounds
See all investors in Cortexyme
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Cortexyme
Who invested in Cortexyme?
Cortexyme has 11 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cortexyme raised?
Cortexyme has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Cortexyme last raise money?
Cortexyme's most recent round on record is a Series B, in May 2018.
What does Cortexyme do?
Founded in 2012 and based in California, US, Cortexyme, Inc.
Where is Cortexyme headquartered?
Cortexyme is headquartered in San Francisco, US.
Which VCs invest in companies like Cortexyme?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Cortexyme's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Cortexyme? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.